https://stock.noler.com/us/stock/repros-therapeutics-inc https://stock.noler.com/us/stock/repros-therapeutics-inc/accounts-payable https://stock.noler.com/us/stock/repros-therapeutics-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/repros-therapeutics-inc/accounts-payable-and-accrued-liabilities-noncurrent https://stock.noler.com/us/stock/repros-therapeutics-inc/accrued-liabilities-current https://stock.noler.com/us/stock/repros-therapeutics-inc/accumulated-depreciation https://stock.noler.com/us/stock/repros-therapeutics-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/repros-therapeutics-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/repros-therapeutics-inc/additional-paid-in-capital https://stock.noler.com/us/stock/repros-therapeutics-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/repros-therapeutics-inc/amended-reports-10-k https://stock.noler.com/us/stock/repros-therapeutics-inc/amended-reports-10-q https://stock.noler.com/us/stock/repros-therapeutics-inc/amortization-of-financing-costs https://stock.noler.com/us/stock/repros-therapeutics-inc/antidilutive-securities-excluded-from-computation-of-earnings-per-share-amount https://stock.noler.com/us/stock/repros-therapeutics-inc/basic-shares https://stock.noler.com/us/stock/repros-therapeutics-inc/buybacks-form-sc-to-i https://stock.noler.com/us/stock/repros-therapeutics-inc/buybacks-share-repurchases https://stock.noler.com/us/stock/repros-therapeutics-inc/buybacks-shares-repurchased https://stock.noler.com/us/stock/repros-therapeutics-inc/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/repros-therapeutics-inc/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/repros-therapeutics-inc/capital-expenditures https://stock.noler.com/us/stock/repros-therapeutics-inc/cash-acquired-from-acquisition https://stock.noler.com/us/stock/repros-therapeutics-inc/cash-and-equivalents https://stock.noler.com/us/stock/repros-therapeutics-inc/cash-and-restricted-cash https://stock.noler.com/us/stock/repros-therapeutics-inc/cash-cash-equivalents-and-short-term-investments https://stock.noler.com/us/stock/repros-therapeutics-inc/cash-flow-breakdown https://stock.noler.com/us/stock/repros-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/repros-therapeutics-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights-1 https://stock.noler.com/us/stock/repros-therapeutics-inc/class-of-warrant-or-right-number-of-securities-called-by-warrants-or-rights https://stock.noler.com/us/stock/repros-therapeutics-inc/clinical-trials https://stock.noler.com/us/stock/repros-therapeutics-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/repros-therapeutics-inc/common-stock-value https://stock.noler.com/us/stock/repros-therapeutics-inc/costs-and-expenses https://stock.noler.com/us/stock/repros-therapeutics-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/repros-therapeutics-inc/current-assets https://stock.noler.com/us/stock/repros-therapeutics-inc/current-liabilities https://stock.noler.com/us/stock/repros-therapeutics-inc/damages-sought-value https://stock.noler.com/us/stock/repros-therapeutics-inc/deferred-income-tax-liabilities https://stock.noler.com/us/stock/repros-therapeutics-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/repros-therapeutics-inc/deferred-tax-assets-inventory https://stock.noler.com/us/stock/repros-therapeutics-inc/deferred-tax-assets-liabilities-net https://stock.noler.com/us/stock/repros-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/repros-therapeutics-inc/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/repros-therapeutics-inc/deferred-tax-assets-tax-credit-carryforwards-research https://stock.noler.com/us/stock/repros-therapeutics-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/repros-therapeutics-inc/deferred-tax-liabilities-deferred-expense-capitalized-patent-costs https://stock.noler.com/us/stock/repros-therapeutics-inc/depreciation https://stock.noler.com/us/stock/repros-therapeutics-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/repros-therapeutics-inc/derivative-liabilities https://stock.noler.com/us/stock/repros-therapeutics-inc/derivative-liabilities-noncurrent https://stock.noler.com/us/stock/repros-therapeutics-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/repros-therapeutics-inc/diluted-shares https://stock.noler.com/us/stock/repros-therapeutics-inc/dilutive-shares https://stock.noler.com/us/stock/repros-therapeutics-inc/discontinued-operation-gain-loss-on-disposal-of-discontinued-operation-net-of-tax https://stock.noler.com/us/stock/repros-therapeutics-inc/discontinued-operation-income-loss-from-discontinued-operation-during-phase-out-period-net-of-tax https://stock.noler.com/us/stock/repros-therapeutics-inc/due-to-employees-noncurrent https://stock.noler.com/us/stock/repros-therapeutics-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/repros-therapeutics-inc/eps https://stock.noler.com/us/stock/repros-therapeutics-inc/eps-basic https://stock.noler.com/us/stock/repros-therapeutics-inc/equity-issuance-per-share-amount https://stock.noler.com/us/stock/repros-therapeutics-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/repros-therapeutics-inc/fair-value-adjustment-of-warrants https://stock.noler.com/us/stock/repros-therapeutics-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/repros-therapeutics-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/repros-therapeutics-inc/financing-cash-flow https://stock.noler.com/us/stock/repros-therapeutics-inc/finite-lived-intangible-assets-accumulated-amortization https://stock.noler.com/us/stock/repros-therapeutics-inc/finite-lived-patents-gross https://stock.noler.com/us/stock/repros-therapeutics-inc/form-d-stocks https://stock.noler.com/us/stock/repros-therapeutics-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/repros-therapeutics-inc/gains-losses-on-sales-of-assets https://stock.noler.com/us/stock/repros-therapeutics-inc/general-and-administrative-expense https://stock.noler.com/us/stock/repros-therapeutics-inc/impairment-of-intangible-assets-excluding-goodwill https://stock.noler.com/us/stock/repros-therapeutics-inc/income-loss-before-extraordinary-items-and-cumulative-effect-of-change-in-accounting-principle https://stock.noler.com/us/stock/repros-therapeutics-inc/income-loss-from https://stock.noler.com/us/stock/repros-therapeutics-inc/income-loss-from-discontinued-operations-net-of-tax https://stock.noler.com/us/stock/repros-therapeutics-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/repros-therapeutics-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/repros-therapeutics-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/repros-therapeutics-inc/increase-decrease-in-receivables https://stock.noler.com/us/stock/repros-therapeutics-inc/incremental-common-shares-attributable-to-share-based-payment-arrangements https://stock.noler.com/us/stock/repros-therapeutics-inc/insider-transactions-other https://stock.noler.com/us/stock/repros-therapeutics-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/repros-therapeutics-inc/insider-transactions-stock-options/purchases https://stock.noler.com/us/stock/repros-therapeutics-inc/insider-transactions-stock-options/sales https://stock.noler.com/us/stock/repros-therapeutics-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/repros-therapeutics-inc/inventory-lifo-reserve https://stock.noler.com/us/stock/repros-therapeutics-inc/inventory-write-down https://stock.noler.com/us/stock/repros-therapeutics-inc/investing-cash-flow https://stock.noler.com/us/stock/repros-therapeutics-inc/investment-income-interest https://stock.noler.com/us/stock/repros-therapeutics-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/repros-therapeutics-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/repros-therapeutics-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/repros-therapeutics-inc/licenses-revenue https://stock.noler.com/us/stock/repros-therapeutics-inc/net-cash-from-financing-activities https://stock.noler.com/us/stock/repros-therapeutics-inc/net-cash-from-investing-activities https://stock.noler.com/us/stock/repros-therapeutics-inc/net-cash-from-operating-activities https://stock.noler.com/us/stock/repros-therapeutics-inc/net-change-in-cash https://stock.noler.com/us/stock/repros-therapeutics-inc/net-income https://stock.noler.com/us/stock/repros-therapeutics-inc/new-accounting-pronouncement-or-change-in-accounting-principle-effect-of-change-on-net-income https://stock.noler.com/us/stock/repros-therapeutics-inc/noninterest-income-other-operating-income https://stock.noler.com/us/stock/repros-therapeutics-inc/operating-cash-flow https://stock.noler.com/us/stock/repros-therapeutics-inc/operating-lease-payments-due https://stock.noler.com/us/stock/repros-therapeutics-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/repros-therapeutics-inc/operating-lease-payments-due-in-five-years https://stock.noler.com/us/stock/repros-therapeutics-inc/operating-lease-payments-due-in-four-years https://stock.noler.com/us/stock/repros-therapeutics-inc/operating-lease-payments-due-in-three-years https://stock.noler.com/us/stock/repros-therapeutics-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/repros-therapeutics-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/repros-therapeutics-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/repros-therapeutics-inc/other-cost-and-expense-operating https://stock.noler.com/us/stock/repros-therapeutics-inc/other-noncash-income https://stock.noler.com/us/stock/repros-therapeutics-inc/other-noncash-income-expense https://stock.noler.com/us/stock/repros-therapeutics-inc/other-nonoperating-income https://stock.noler.com/us/stock/repros-therapeutics-inc/paid-in-capital-other https://stock.noler.com/us/stock/repros-therapeutics-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/repros-therapeutics-inc/paid-in-capital-shares-issued-issuance-costs https://stock.noler.com/us/stock/repros-therapeutics-inc/paid-in-capital-stock-compensation https://stock.noler.com/us/stock/repros-therapeutics-inc/paid-in-capital-warrant-issued https://stock.noler.com/us/stock/repros-therapeutics-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/repros-therapeutics-inc/payments-of-stock-issuance-costs https://stock.noler.com/us/stock/repros-therapeutics-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/repros-therapeutics-inc/payments-to-acquire-marketable-securities https://stock.noler.com/us/stock/repros-therapeutics-inc/payments-to-acquire-other-productive-assets https://stock.noler.com/us/stock/repros-therapeutics-inc/preferred-shares-facts https://stock.noler.com/us/stock/repros-therapeutics-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/repros-therapeutics-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/repros-therapeutics-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/repros-therapeutics-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/repros-therapeutics-inc/preferred-stock-value https://stock.noler.com/us/stock/repros-therapeutics-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/repros-therapeutics-inc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/repros-therapeutics-inc/proceeds-from-divestiture-of-businesses-net-of-cash-divested https://stock.noler.com/us/stock/repros-therapeutics-inc/proceeds-from-divestiture-of-interest-in-consolidated-subsidiaries https://stock.noler.com/us/stock/repros-therapeutics-inc/proceeds-from-issuance-of-preferred-stock-and-preference-stock https://stock.noler.com/us/stock/repros-therapeutics-inc/proceeds-from-issuance-of-private-placement https://stock.noler.com/us/stock/repros-therapeutics-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/repros-therapeutics-inc/proceeds-from-sale-of-property-plant-and-equipment https://stock.noler.com/us/stock/repros-therapeutics-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/repros-therapeutics-inc/proceeds-from-stock-options-exercised https://stock.noler.com/us/stock/repros-therapeutics-inc/proceeds-from-warrant-exercises https://stock.noler.com/us/stock/repros-therapeutics-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/repros-therapeutics-inc/property-plant-equipment https://stock.noler.com/us/stock/repros-therapeutics-inc/public-float https://stock.noler.com/us/stock/repros-therapeutics-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/repros-therapeutics-inc/research-and-development https://stock.noler.com/us/stock/repros-therapeutics-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/repros-therapeutics-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/repros-therapeutics-inc/restricted-cash-and-cash-equivalents-noncurrent https://stock.noler.com/us/stock/repros-therapeutics-inc/retained-earnings https://stock.noler.com/us/stock/repros-therapeutics-inc/revenue https://stock.noler.com/us/stock/repros-therapeutics-inc/revenue-from-grants https://stock.noler.com/us/stock/repros-therapeutics-inc/royalty-revenue https://stock.noler.com/us/stock/repros-therapeutics-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-10-k https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-10-q https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-15-12b https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-25 https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-25-nse https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-8-a12b https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-8-k https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-certnas https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-ct-order https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-def-14a https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-defa14a https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-defr14a https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-sc-14d9 https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-sc-to-c https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-sc-to-t https://stock.noler.com/us/stock/repros-therapeutics-inc/sec-filings-sc14d9c https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-424b4 https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-424b5 https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-fwp https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-s-1mef https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-s-3 https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-s-3mef https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/repros-therapeutics-inc/secondary-offerings-form-s-8-pos https://stock.noler.com/us/stock/repros-therapeutics-inc/shareholders-equity https://stock.noler.com/us/stock/repros-therapeutics-inc/shares-authorized https://stock.noler.com/us/stock/repros-therapeutics-inc/shares-issued https://stock.noler.com/us/stock/repros-therapeutics-inc/shares-issued-2 https://stock.noler.com/us/stock/repros-therapeutics-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/repros-therapeutics-inc/shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/repros-therapeutics-inc/shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-award-fair-value-assumptions-exercise-price https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-award-fair-value-assumptions-expected-dividend-rate https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-award-fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-award-fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-award-number-of-shares-available-for-grant https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-based-compensation https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-for-acquisitions https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-shares-conversion-of-convertible-securities https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-shares-employee-stock-ownership-plan https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-shares-espps https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-shares-other https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-shares-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-value-employee-stock-ownership-plan https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-value-espp https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-value-restricted-stock-award-net-of-forfeitures https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-value-stock-options-exercised https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-shares-issued-value-treasury-stock-reissued https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-issued-value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-options-exercisable-intrinsic-value https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/repros-therapeutics-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/repros-therapeutics-inc/total-assets https://stock.noler.com/us/stock/repros-therapeutics-inc/total-liabilities https://stock.noler.com/us/stock/repros-therapeutics-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/repros-therapeutics-inc/treasury-stock-shares https://stock.noler.com/us/stock/repros-therapeutics-inc/treasury-stock-value https://stock.noler.com/us/stock/repros-therapeutics-inc/valuation-allowance-amount https://stock.noler.com/us/stock/repros-therapeutics-inc/weighted-average-number-of-share-outstanding-basic-and-diluted